- Belimumab Granted Orphan Drug Status for SSc
- Implementation of Naloxone Prescribing, Overdose Quality Improvement Program
- Declining Physical Function Is Accelerated Among Postmenopausal Cancer Survivors
- FDA Revises EUA Halting Use of Tixagevimab Plus Cilgavimab for COVID-19
- Ability to Smell May Be Predictive Marker of Frailty
- Nearly Half of People With Dementia Experience a Fall Annually
- Biden to Lift COVID-19 Emergencies in May
- Many US Women Confused About Medical Abortion
- Women With RA, SLE, and Their Infants, Have Greater Risk for Adverse Outcomes
- Risk for Incident AF Similar With Different ULTs in Gout
- Adalimumab Biosimilar Now Available
- COVID-19 BNT162b2 Vaccine More Effective Against Delta vs Omicron in Adolescents
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
